Allyx Therapeutics
New Haven · Founded 2018
About Allyx Therapeutics
Allyx Therapeutics is a clinical-stage biotechnology company that develops therapies to reverse neurodegeneration. Allyx Therapeutics' product is an orally bioavailable small molecule that acts as a silent allosteric modulator, enabling clinicians to get a drug capable of delivering a disease-modifying approach and preserving cognition in patients.
Company Facts
- Founded: 2018
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $13.4M
- Last round: Grant (Oct 2024)
- Website: https://allyxthera.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care, Life Science, Medical
Social Profiles
Canonical: https://fsome.com/organization/allyx-therapeutics-70504 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.